Top Key Companies for AI Drug Discovery Platform Market: Exscientia, Iktos, Delta4, Healx, Innoplexus, BenevolentAI, Evaxion, Genome Biologics, Novadiscovery, Nuritas, CytoReason, Turbine Simulated Cell Technologies, Atomwise, Recursion, Insilico Medicine, Relay Therapeutics, Pfizer, Janssen, AstraZeneca, Beijing Iipharma.
Global AI Drug Discovery Platform Market Size was estimated at USD 569 million in 2022 and is projected to reach USD 762.51 million by 2028, exhibiting a CAGR of 5% during the forecast period.
Global AI Drug Discovery Platform Market Overview And Scope:
The Global AI Drug Discovery Platform Market Report 2023 provides comprehensive analysis of market development components, patterns, flows, and sizes. This research study of AI Drug Discovery Platform utilized both primary and secondary data sources to calculate present and past market values to forecast potential market management for the forecast period between 2023 and 2030. It includes the study of a wide range of industry parameters, including government policies, market environments, competitive landscape, historical data, current market trends, technological innovations, upcoming technologies, and technological progress within related industries. Additionally, the report provides an in-depth analysis of the value chain and supply chain to demonstrate how value is added at every stage in the product lifecycle. The study incorporates market dynamics such as drivers, restraints/challenges, trends, and their impact on the market.
This Market Research Report provides a comprehensive analysis of the global AI Drug Discovery Platform Market and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on AI Drug Discovery Platform portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms' unique position in an accelerating global AI Drug Discovery Platform market.
Global AI Drug Discovery Platform Market Segmentation
By Type, AI Drug Discovery Platform market has been segmented into:
Drug Discovery
Drug Design
By Application, AI Drug Discovery Platform market has been segmented into:
Pharmaceutical Company
Biotech Company
Contract Research Organization
Others
Regional Analysis of AI Drug Discovery Platform Market:
North America (U.S., Canada, Mexico)
Eastern Europe (Bulgaria, The Czech Republic, Hungary, Poland, Romania, Rest of Eastern Europe)
Western Europe (Germany, UK, France, Netherlands, Italy, Russia, Spain, Rest of Western Europe)
Asia-Pacific (China, India, Japan, Singapore, Australia, New Zealand, Rest of APAC)
South America (Brazil, Argentina, Rest of SA)
Middle East & Africa (Turkey, Bahrain, Kuwait, Saudi Arabia, Qatar, UAE, Israel, South Africa)
Competitive Landscape of AI Drug Discovery Platform Market:
Competitive analysis is the study of strength and weakness, market investment, market share, market sales volume, market trends of major players in the market.The AI Drug Discovery Platform market study focused on including all the primary level, secondary level and tertiary level competitors in the report.The data generated by conducting the primary and secondary research. The report covers detail analysis of driver, constraints and scope for new players entering the AI Drug Discovery Platform market.
Top Key Companies Covered in AI Drug Discovery Platform market are:
Exscientia
Iktos
Delta4
Healx
Innoplexus
BenevolentAI
Evaxion
Genome Biologics
Novadiscovery
Nuritas
CytoReason
Turbine Simulated Cell Technologies
Atomwise
Recursion
Insilico Medicine
Relay Therapeutics
Pfizer
Janssen
AstraZeneca
Beijing Iipharma
Chapter 1: Introduction
1.1 Research Objectives
1.2 Research Methodology
1.3 Research Process
1.4 Scope and Coverage
1.4.1 Market Definition
1.4.2 Key Questions Answered
1.5 Market Segmentation
Chapter 2:Executive Summary
Chapter 3:Growth Opportunities By Segment
3.1 By Type
3.2 By Application
Chapter 4: Market Landscape
4.1 Porter's Five Forces Analysis
4.1.1 Bargaining Power of Supplier
4.1.2 Threat of New Entrants
4.1.3 Threat of Substitutes
4.1.4 Competitive Rivalry
4.1.5 Bargaining Power Among Buyers
4.2 Industry Value Chain Analysis
4.3 Market Dynamics
4.3.1 Drivers
4.3.2 Restraints
4.3.3 Opportunities
4.5.4 Challenges
4.4 Pestle Analysis
4.5 Technological Roadmap
4.6 Regulatory Landscape
4.7 SWOT Analysis
4.8 Price Trend Analysis
4.9 Patent Analysis
4.10 Analysis of the Impact of Covid-19
4.10.1 Impact on the Overall Market
4.10.2 Impact on the Supply Chain
4.10.3 Impact on the Key Manufacturers
4.10.4 Impact on the Pricing
Chapter 5: AI Drug Discovery Platform Market by Type
5.1 AI Drug Discovery Platform Market Overview Snapshot and Growth Engine
5.2 AI Drug Discovery Platform Market Overview
5.3 Drug Discovery
5.3.1 Introduction and Market Overview
5.3.2 Historic and Forecasted Market Size (2016-2030F)
5.3.3 Key Market Trends, Growth Factors and Opportunities
5.3.4 Drug Discovery: Geographic Segmentation
5.4 Drug Design
5.4.1 Introduction and Market Overview
5.4.2 Historic and Forecasted Market Size (2016-2030F)
5.4.3 Key Market Trends, Growth Factors and Opportunities
5.4.4 Drug Design: Geographic Segmentation
Chapter 6: AI Drug Discovery Platform Market by Application
6.1 AI Drug Discovery Platform Market Overview Snapshot and Growth Engine
6.2 AI Drug Discovery Platform Market Overview
6.3 Pharmaceutical Company
6.3.1 Introduction and Market Overview
6.3.2 Historic and Forecasted Market Size (2016-2030F)
6.3.3 Key Market Trends, Growth Factors and Opportunities
6.3.4 Pharmaceutical Company: Geographic Segmentation
6.4 Biotech Company
6.4.1 Introduction and Market Overview
6.4.2 Historic and Forecasted Market Size (2016-2030F)
6.4.3 Key Market Trends, Growth Factors and Opportunities
6.4.4 Biotech Company: Geographic Segmentation
6.5 Contract Research Organization
6.5.1 Introduction and Market Overview
6.5.2 Historic and Forecasted Market Size (2016-2030F)
6.5.3 Key Market Trends, Growth Factors and Opportunities
6.5.4 Contract Research Organization: Geographic Segmentation
6.6 Others
6.6.1 Introduction and Market Overview
6.6.2 Historic and Forecasted Market Size (2016-2030F)
6.6.3 Key Market Trends, Growth Factors and Opportunities
6.6.4 Others: Geographic Segmentation
Chapter 7: Company Profiles and Competitive Analysis
7.1 Competitive Landscape
7.1.1 Competitive Positioning
7.1.2 AI Drug Discovery Platform Sales and Market Share By Players
7.1.3 Industry BCG Matrix
7.1.4 Heat Map Analysis
7.1.5 AI Drug Discovery Platform Industry Concentration Ratio (CR5 and HHI)
7.1.6 Top 5 AI Drug Discovery Platform Players Market Share
7.1.7 Mergers and Acquisitions
7.1.8 Business Strategies By Top Players
7.2 EXSCIENTIA
7.2.1 Company Overview
7.2.2 Key Executives
7.2.3 Company Snapshot
7.2.4 Operating Business Segments
7.2.5 Product Portfolio
7.2.6 Business Performance
7.2.7 Key Strategic Moves and Recent Developments
7.2.8 SWOT Analysis
7.3 IKTOS
7.4 DELTA4
7.5 HEALX
7.6 INNOPLEXUS
7.7 BENEVOLENTAI
7.8 EVAXION
7.9 GENOME BIOLOGICS
7.10 NOVADISCOVERY
7.11 NURITAS
7.12 CYTOREASON
7.13 TURBINE SIMULATED CELL TECHNOLOGIES
7.14 ATOMWISE
7.15 RECURSION
7.16 INSILICO MEDICINE
7.17 RELAY THERAPEUTICS
7.18 PFIZER
7.19 JANSSEN
7.20 ASTRAZENECA
7.21 BEIJING IIPHARMA
Chapter 8: Global AI Drug Discovery Platform Market Analysis, Insights and Forecast, 2016-2030
8.1 Market Overview
8.2 Historic and Forecasted Market Size By Type
8.2.1 Drug Discovery
8.2.2 Drug Design
8.3 Historic and Forecasted Market Size By Application
8.3.1 Pharmaceutical Company
8.3.2 Biotech Company
8.3.3 Contract Research Organization
8.3.4 Others
Chapter 9: North America AI Drug Discovery Platform Market Analysis, Insights and Forecast, 2016-2030
9.1 Key Market Trends, Growth Factors and Opportunities
9.2 Impact of Covid-19
9.3 Key Players
9.4 Key Market Trends, Growth Factors and Opportunities
9.4 Historic and Forecasted Market Size By Type
9.4.1 Drug Discovery
9.4.2 Drug Design
9.5 Historic and Forecasted Market Size By Application
9.5.1 Pharmaceutical Company
9.5.2 Biotech Company
9.5.3 Contract Research Organization
9.5.4 Others
9.6 Historic and Forecast Market Size by Country
9.6.1 US
9.6.2 Canada
9.6.3 Mexico
Chapter 10: Eastern Europe AI Drug Discovery Platform Market Analysis, Insights and Forecast, 2016-2030
10.1 Key Market Trends, Growth Factors and Opportunities
10.2 Impact of Covid-19
10.3 Key Players
10.4 Key Market Trends, Growth Factors and Opportunities
10.4 Historic and Forecasted Market Size By Type
10.4.1 Drug Discovery
10.4.2 Drug Design
10.5 Historic and Forecasted Market Size By Application
10.5.1 Pharmaceutical Company
10.5.2 Biotech Company
10.5.3 Contract Research Organization
10.5.4 Others
10.6 Historic and Forecast Market Size by Country
10.6.1 Bulgaria
10.6.2 The Czech Republic
10.6.3 Hungary
10.6.4 Poland
10.6.5 Romania
10.6.6 Rest of Eastern Europe
Chapter 11: Western Europe AI Drug Discovery Platform Market Analysis, Insights and Forecast, 2016-2030
11.1 Key Market Trends, Growth Factors and Opportunities
11.2 Impact of Covid-19
11.3 Key Players
11.4 Key Market Trends, Growth Factors and Opportunities
11.4 Historic and Forecasted Market Size By Type
11.4.1 Drug Discovery
11.4.2 Drug Design
11.5 Historic and Forecasted Market Size By Application
11.5.1 Pharmaceutical Company
11.5.2 Biotech Company
11.5.3 Contract Research Organization
11.5.4 Others
11.6 Historic and Forecast Market Size by Country
11.6.1 Germany
11.6.2 UK
11.6.3 France
11.6.4 Netherlands
11.6.5 Italy
11.6.6 Russia
11.6.7 Spain
11.6.8 Rest of Western Europe
Chapter 12: Asia Pacific AI Drug Discovery Platform Market Analysis, Insights and Forecast, 2016-2030
12.1 Key Market Trends, Growth Factors and Opportunities
12.2 Impact of Covid-19
12.3 Key Players
12.4 Key Market Trends, Growth Factors and Opportunities
12.4 Historic and Forecasted Market Size By Type
12.4.1 Drug Discovery
12.4.2 Drug Design
12.5 Historic and Forecasted Market Size By Application
12.5.1 Pharmaceutical Company
12.5.2 Biotech Company
12.5.3 Contract Research Organization
12.5.4 Others
12.6 Historic and Forecast Market Size by Country
12.6.1 China
12.6.2 India
12.6.3 Japan
12.6.4 South Korea
12.6.5 Malaysia
12.6.6 Thailand
12.6.7 Vietnam
12.6.8 The Philippines
12.6.9 Australia
12.6.10 New Zealand
12.6.11 Rest of APAC
Chapter 13: Middle East & Africa AI Drug Discovery Platform Market Analysis, Insights and Forecast, 2016-2030
13.1 Key Market Trends, Growth Factors and Opportunities
13.2 Impact of Covid-19
13.3 Key Players
13.4 Key Market Trends, Growth Factors and Opportunities
13.4 Historic and Forecasted Market Size By Type
13.4.1 Drug Discovery
13.4.2 Drug Design
13.5 Historic and Forecasted Market Size By Application
13.5.1 Pharmaceutical Company
13.5.2 Biotech Company
13.5.3 Contract Research Organization
13.5.4 Others
13.6 Historic and Forecast Market Size by Country
13.6.1 Turkey
13.6.2 Bahrain
13.6.3 Kuwait
13.6.4 Saudi Arabia
13.6.5 Qatar
13.6.6 UAE
13.6.7 Israel
13.6.8 South Africa
Chapter 14: South America AI Drug Discovery Platform Market Analysis, Insights and Forecast, 2016-2030
14.1 Key Market Trends, Growth Factors and Opportunities
14.2 Impact of Covid-19
14.3 Key Players
14.4 Key Market Trends, Growth Factors and Opportunities
14.4 Historic and Forecasted Market Size By Type
14.4.1 Drug Discovery
14.4.2 Drug Design
14.5 Historic and Forecasted Market Size By Application
14.5.1 Pharmaceutical Company
14.5.2 Biotech Company
14.5.3 Contract Research Organization
14.5.4 Others
14.6 Historic and Forecast Market Size by Country
14.6.1 Brazil
14.6.2 Argentina
14.6.3 Rest of SA
Chapter 15 Investment Analysis
Chapter 16 Analyst Viewpoint and Conclusion
What is the forecast period in the AI Drug Discovery Platform Market research report?
The forecast period in the AI Drug Discovery Platform Market research report is 2023-2030.
Who are the key players in AI Drug Discovery Platform Market?
Exscientia, Iktos, Delta4, Healx, Innoplexus, BenevolentAI, Evaxion, Genome Biologics, Novadiscovery, Nuritas, CytoReason, Turbine Simulated Cell Technologies, Atomwise, Recursion, Insilico Medicine, Relay Therapeutics, Pfizer, Janssen, AstraZeneca, Beijing Iipharma
How big is the AI Drug Discovery Platform Market?
Global AI Drug Discovery Platform Market Size was estimated at USD 569 million in 2022 and is projected to reach USD 762.51 million by 2028, exhibiting a CAGR of 5% during the forecast period.
What are the segments of the AI Drug Discovery Platform Market?
The AI Drug Discovery Platform Market is segmented into Type and Application. By Type, Drug Discovery, Drug Design and By Application, Pharmaceutical Company, Biotech Company, Contract Research Organization, Others
AI Drug Discovery Platform
Exscientia, Iktos, Delta4, Healx, Innoplexus, BenevolentAI, Evaxion, Genome Biologics, Novadiscovery, Nuritas, CytoReason, Turbine Simulated Cell Technologies, Atomwise, Recursion, Insilico Medicine, Relay Therapeutics, Pfizer, Janssen, AstraZeneca, Beijing Iipharma
Drug Discovery, Drug Design
Pharmaceutical Company, Biotech Company, Contract Research Organization, Others
